Corcept Therapeutics Incorporated
CORT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $8,606 | $7,642 | $11,891 | $5,223 |
| - Cash | $125 | $103 | $90 | $128 |
| + Debt | $6 | $7 | $7 | $7 |
| Enterprise Value | $8,487 | $7,546 | $11,808 | $5,102 |
| Revenue | $208 | $194 | $157 | $182 |
| % Growth | 6.8% | 23.7% | -13.6% | – |
| Gross Profit | $203 | $191 | $155 | $179 |
| % Margin | 97.8% | 98.2% | 98.5% | 98.4% |
| EBITDA | $16 | $27 | $4 | $26 |
| % Margin | 7.6% | 14% | 2.5% | 14.1% |
| Net Income | $19 | $35 | $20 | $30 |
| % Margin | 9.3% | 18.1% | 12.9% | 16.7% |
| EPS Diluted | 0.16 | 0.29 | 0.17 | 0.26 |
| % Growth | -44.8% | 70.6% | -34.6% | – |
| Operating Cash Flow | $54 | $44 | $5 | $59 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $54 | $44 | $5 | $59 |